Subnational Burden of Disease Studies: Mexico Leads the Way
article has not abstract
Vyšlo v časopise:
Subnational Burden of Disease Studies: Mexico Leads the Way. PLoS Med 5(6): e138. doi:10.1371/journal.pmed.0050138
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.0050138
Souhrn
article has not abstract
Zdroje
1. World Bank
1993
World Development Report 1993: Investing in health.
Available: http://www-wds.worldbank.org/external/default/main?pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&siteName=WDS&entityID=000009265_3970716142319. Accessed 14 May 2008
2. LopezADMathersCDEzzatiMJamisonDTMurrayCJL
2006
Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data.
Lancet
367
1747
1757
3. MichaudCMMcKennaMTBeggSTomijimaNMajmudarM
2006
The burden of disease and injury in the United States 1996.
Popul Health Metr
4
11
60
4. BeggSVosTBarkerBStevensonCStanleyL
2007
The burden of disease and injury in Australia 2003. Australian Institute of Health and Welfare.
Available: http://www.aihw.gov.au/publications/index.cfm/title/10317. Accessed 14 May 2008
5. TobiasMI
1999
Our Health, Our Future. Hauora Pakari Koiora Roa. New Zealand Ministry of Health.
Available: http://www.moh.govt.nz/moh.nsf/ae8bff4c2724ed6f4c256669006aed56/6910156be95e706e4c2568800002e403?OpenDocument. Accessed 14 May 2008
6. MelseJMEssink-BotM-LKramersPGNHoeymansN
2000
A national burden of disease calculation: Dutch disability-adjusted life-years.
Am J Public Health
90
1241
1247
7. LapostolleALefrancAGremyISpiraA
2007
Sensitivity analysis in summary measure of population health in France.
Eur J Public Health
18
195
200
8. Public Health Agency of Canada
2008
Population health impact of disease in Canada.
Available: http://www.phac-aspc.gc.ca/phi-isp/summary_measures-eng.php. Accessed 14 May 2008
9. StevensGDiasRHThomasKJARiveraJACarvalhoN
2008
Characterizing the epidemiological transition in Mexico: National and subnational burden of diseases, injuries, and risk factors.
PLoS Med
5
6
e125
doi:10.1371/journal.pmed.0050125
10. UstunTBRehmJChatterjiSSaxenaSTrotterR
1999
Multiple-informant ranking of the disabling effects of different health conditions in 14 countries.
Lancet
354
111
115
11. van BaalPHMHoeymansNHoogenveenRTde WitGAWestertGP
2006
Disability weights for comorbidity and their influence on health-adjusted life expectancy.
Popul Health Metr
4
1
7
12. FlanaganWBoswell-PurdyJLe PetitCBerthelotJ-M
2005
Estimating summary measures of health: A structured workbook approach.
Popul Health Metr
3
5
17
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2008 Číslo 6
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- Ethical Implications of Modifying Lethal Injection Protocols
- Subnational Burden of Disease Studies: Mexico Leads the Way
- Guidelines for Reporting Health Research: The EQUATOR Network's Survey of Guideline Authors
- How Might Cocaine Interfere with Brain Development?